文献速递帕金森病与运动障碍癫痫

抗癫痫药物与新发帕金森病之间的关联

Association Between Antiepileptic Drugs and Incident Parkinson Disease.
PubMed 文献 · JAMA Neurol · 2023-01-01

这项在UK Biobank中开展的巢式病例对照研究纳入1433例医院统计编码诊断的帕金森病病例和8598名对照,发现抗癫痫药物处方与新发帕金森病存在关联(OR 1.80,95%CI 1.35-2.40),且处方次数更多和多种抗癫痫药物与更高风险呈趋势。

要点

  • 抗癫痫药物处方与新发帕金森病相关(OR 1.80,95%CI 1.35-2.40)。
  • 处方次数更多及使用多种抗癫痫药物与帕金森病风险升高呈趋势。
  • 该研究为首次系统评估最常见抗癫痫药物与新发帕金森病风险的研究。

核心结论

  • 该研究首次系统评估最常见抗癫痫药物处方者的帕金森病风险,发现抗癫痫药物与新发帕金森病存在关联证据。

研究设计与样本

  • 巢式病例对照研究,数据来自UK Biobank,2006年开始收集数据,2021年6月30日提取数据。
  • 纳入有初级保健处方数据链接的个体,共222106人符合入组条件,排除1477人(49人仅有自报帕金森病诊断,1428人匹配变量缺失)。
  • 病例为医院统计编码诊断的帕金森病个体,对照按年龄、性别、种族和民族及社会经济地位6:1匹配。
  • 暴露为初级保健处方数据中卡马西平、拉莫三嗪、左乙拉西坦和丙戊酸钠的处方记录。

主要发现

  • 分析纳入1433例医院统计编码诊断的帕金森病病例和8598名对照。
  • 1433例病例中873例(60.9%)为男性,1397例(97.5%)种族和民族记录为白人,中位年龄71岁(IQR 65-75岁)。
  • 抗癫痫药物处方与新发帕金森病的OR为1.80(95%CI 1.35-2.40)。
  • 处方次数更多和多种抗癫痫药物与帕金森病风险升高呈趋势。

关键数值与推荐

  • 抗癫痫药物处方与新发帕金森病关联的OR为1.80(95%CI 1.35-2.40)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Recent studies have highlighted an association between epilepsy and Parkinson disease (PD). The role of antiepileptic drugs (AEDs) has not been explored. OBJECTIVE: To investigate the association between AEDs and incident PD. DESIGN, SETTING, AND PARTICIPANTS: This nested case-control study started collecting data from the UK Biobank (UKB) in 2006, and data were extracted on June 30, 2021. Individuals with linked primary care prescription data were included. Cases were defined as individuals with a Hospital Episode Statistics (HES)-coded diagnosis of PD. Controls were matched 6:1 for age, sex, race and ethnicity, and socioeconomic status. Prescription records were searched for AEDs prescribed prior to diagnosis of PD. The UKB is a longitudinal cohort study with more than 500 000 participants; 45% of individuals in the UKB have linked primary care prescription data. Participants living in the UK aged between 40 and 69 years were recruited to the UKB between 2006 and 2010. All participants with UKB-linked primary care prescription data (n = 222 106) were eligible for enrollment in the study. Individuals with only a self-reported PD diagnosis or missing data for the matching variables were excluded. In total, 1477 individuals were excluded; 49 were excluded due to having only self-reported PD, and 1428 were excluded due to missing data. EXPOSURES: Exposure to AEDs (carbamazepine, lamotrigine, levetiracetam, and sodium valproate) was defined using routinely collected prescription data derived from primary care. MAIN OUTCOMES AND MEASURES: Odds ratios and 95% CIs were calculated using adjusted logistic regression models for individuals prescribed AEDs before the first date of HES-coded diagnosis of PD. RESULTS: In this case-control study, there were 1433 individuals with an HES-coded PD diagnosis (cases) and 8598 controls in the analysis. Of the 1433 individuals, 873 (60.9%) were male, 1397 (97.5%) had their race and ethnicity recorded as White, and their median age was 71 years (IQR, 65-75 years). An association was found between AED prescriptions and incident PD (odds ratio, 1.80; 95% CI, 1.35-2.40). There was a trend for a greater number of prescription issues and multiple AEDs being associated with a greater risk of PD. CONCLUSIONS AND RELEVANCE: This study, the first to systematically look at PD risk in individuals prescribed the most common AEDs, to our knowledge, found evidence of an association between AEDs and incident PD. With the recent literature demonstrating an association between epilepsy and PD, this study provides further insights.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Belete D, Jacobs BM, Simonet C, et al. Association Between Antiepileptic Drugs and Incident Parkinson Disease. JAMA Neurol. 2023. PMID: 36574240. doi:10.1001/jamaneurol.2022.4699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。